For example, within TMEs of breast and prostate cancers, it was observed that the expression levels of angiogenic factors such as vascular endothelial growth factor (VEGF) and Interleukin 6 (IL-6) are upregulated by the MSCs. The gene discussed is VEGFA; the disease is prostate cancer.